China Resources Double Crane: Wholly-owned subsidiary Sodium Acetate Lin Injection Solution obtains drug registration certificate.

China Resources Shuanghe Announcement: Xi'an Jingxi Shuanghe Pharmaceutical Co., Ltd., a wholly-owned subsidiary, recently received the "Drug Registration Certificate" for the injection of sodium acetate lingers. Sodium acetate ring injection is used to supplement extracellular fluid when circulating blood volume and interstitial fluid are reduced, and to correct metabolic acidosis. Jingxi Shuanghe started the generic drug research and development work for this drug in November 2023, submitted the market approval application to the National Medical Products Administration on September 14, 2024, received the acceptance notice on September 26, 2024, and obtained approval for market on February 25, 2026 from the National Medical Products Administration.